Clinical TrialID 3770
Efficacy of Tyrosine in Restless Legs Syndrome
NCT01494766
Restless Legs Syndrome (RLS)
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 3770
- Evidence Id
- 3770
- Core Evidence Id
- 3770
- Source Clinical Trial Id
- 3744
- Herb2 Clinical Trial Id
- HBCT003744
- Nct Id
- NCT01494766
- Title
- Efficacy of Tyrosine in Restless Legs Syndrome
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Restless Legs Syndrome (RLS)
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DIETARY_SUPPLEMENT: L-Tyrosine
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 5
- Outcome Measure
- International RLS Survey Group (IRLSSG20) Score, Use of this survey to be used as a marker for severity of RLS symptoms and therefore efficacy of this medication., 6 weeks
- Sponsor Collaborator
- Seton Healthcare Family
- Funded By
- OTHER
- Location
- Seton Family of Hospitals, Austin, Texas, 78701, United States
- Other Id
- CR-11-146
- Start Date
- 2012-01
- Primary Completion Date
- 2012-05
- Completion Date
- 2012-11
- First Posted
- 2011-12-19
- Results First Posted
- Last Update Posted
- 2017-04-27
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01494766
- Title Cn
- Title En
- Efficacy of Tyrosine in Restless Legs Syndrome
- Bilingual Status
- semi_complete